Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND – News) and Metabasis Therapeutics, Inc. (NASDAQ: MBRX – News) announced today they have entered into a definitive merger agreement under which Ligand will acquire all of the outstanding shares of Metabasis.
Under the transaction, Metabasis stockholders will receive a cash payment [...]